Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Neoplasms 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hemangioma 2Carcinoma, Non-Small-Cell Lung 2Radiation Pneumonitis 1Radiation Injuries 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Leukemia, Hairy Cell 1Leukemia 1Hepatitis 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Chemical and Drug Induced Liver Injury 1Bulbo-Spinal Atrophy, X-Linked 1Brain Neoplasms 1

Interventions

Docetaxel 137Prednisone 120Abiraterone Acetate 91Leuprolide 86enzalutamide 84Radiotherapy 59bicalutamide 56Magnetic Resonance Spectroscopy 54Goserelin 54Androgen Antagonists 51acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47apalutamide 44abiraterone 34Radiosurgery 31Specimen Handling 30gallium 68 PSMA-11 29Gonadotropin-Releasing Hormone 29cabazitaxel 28Carboplatin 27darolutamide 26Estramustine 24luprolide acetate gel depot 23relugolix 22Metformin 22Triptorelin Pamoate 20sipuleucel-T 19radium Ra 223 dichloride 19Radiation 19pembrolizumab 18deltacortene 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Prostatic Neoplasms × Adrenal Cortex Hormones × Clear all
NCT03050866 2021-08-20

CABA-V7

Erasmus Medical Center

Phase 2 Unknown
140 enrolled
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01393730 2018-03-15

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
40 enrolled 12 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00006371 2012-09-27

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡